What is it about?
The recent evidence of spatiotemporal genomes and tumor evolution has led to the development of breakthrough next-generation sequencing technologies.
Featured Image
Why is it important?
Progress in basic, translational and clinical research and implementation of new discoveries into routine clinical practice is faster in breast cancer than in any other cancer type.
Perspectives
This understanding of molecular mechanisms landscape underlying therapeutic resistance shapes new horizons in robust biomarkers and drug-development strategy to reach precision cancer medicine.
Dr Demosthenes E. Ziogas
Peripheral General Hospital of Ioannina - Xatzikosta
Read the Original
This page is a summary of: Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy, Future Oncology, January 2017, Future Medicine,
DOI: 10.2217/fon-2016-0307.
You can read the full text:
Contributors
The following have contributed to this page
